These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11928379

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
    Cohen G, Courvoisier N, Cohen JD, Zaltni S, Sany J, Combe B.
    Clin Exp Rheumatol; 2005; 23(6):795-800. PubMed ID: 16396697
    [Abstract] [Full Text] [Related]

  • 23. Tuberculosis under anti-TNF therapy: case series of a center (reporting the experience from the period 2006-2019).
    Valido A, Dinis JS, Saavedra MJ, Fonseca JE.
    Acta Reumatol Port; 2020; 45(4):281-287. PubMed ID: 33423034
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Infliximab and brucellosis: not the usual suspects, this time.
    Akgul O, Ozgocmen S.
    Mod Rheumatol; 2011 Jun; 21(3):313-5. PubMed ID: 21243400
    [Abstract] [Full Text] [Related]

  • 28. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition.
    Vassallo R, Matteson E, Thomas CF.
    Chest; 2002 Sep; 122(3):1093-6. PubMed ID: 12226061
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.
    Gin A, Dolianitis C.
    Australas J Dermatol; 2014 May; 55(2):140-1. PubMed ID: 23713793
    [Abstract] [Full Text] [Related]

  • 32. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?
    De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE.
    Infect Control Hosp Epidemiol; 2003 Jul; 24(7):477-82. PubMed ID: 12887234
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.
    Imaizumi K, Sugishita M, Usui M, Kawabe T, Hashimoto N, Hasegawa Y.
    Intern Med; 2006 Jul; 45(10):685-8. PubMed ID: 16778341
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Exacerbation of tuberculosis enteritis after treatment with infliximab.
    Liberopoulos EN, Drosos AA, Elisaf MS.
    Am J Med; 2002 Nov; 113(7):615. PubMed ID: 12459414
    [No Abstract] [Full Text] [Related]

  • 38. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
    Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM.
    N Engl J Med; 2001 Oct 11; 345(15):1098-104. PubMed ID: 11596589
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.